Cargando…

The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma

Post-therapeutic relapse, poor survival rates and increasing incidence justify the search for novel therapeutic targets and strategies in cutaneous malignant melanoma (CMM). Within this context, a potential oncogenic role for TrkA in CMM is suggested by reports of NTRK1 amplification, enhanced TrkA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cappabianca, Lucia, Zelli, Veronica, Pellegrini, Cristina, Sebastiano, Michela, Maccarone, Rita, Clementi, Marco, Chiominto, Alessandro, Ruggeri, Pierdomenico, Cardelli, Ludovica, Ruggieri, Marianna, Sbaffone, Maddalena, Fargnoli, Maria-Concetta, Guadagni, Stefano, Farina, Antonietta R., Mackay, Andrew R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856487/ https://www.ncbi.nlm.nih.gov/pubmed/36672171 http://dx.doi.org/10.3390/cells12020237

Ejemplares similares

The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII
por: Farina, Antonietta Rosella, et al.
Publicado: (2018)

Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells
por: Cappabianca, Lucia, et al.
Publicado: (2022)

Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity
por: Farina, Antonietta Rosella, et al.
Publicado: (2015)

A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target
por: Cappabianca, Lucia, et al.
Publicado: (2019)

TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma
por: Gneo, Luciana, et al.
Publicado: (2016)

TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation
por: Farina, Antonietta Rosella, et al.
Publicado: (2017)

Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A
por: Guadagni, Stefano, et al.
Publicado: (2020)

TrkAIII Promotes Microtubule Nucleation and Assembly at the Centrosome in SH-SY5Y Neuroblastoma Cells, Contributing to an Undifferentiated Anaplastic Phenotype
por: Farina, Antonietta R., et al.
Publicado: (2013)

The TrkAIII Oncoprotein Inhibits Mitochondrial Free Radical ROS-Induced Death of SH-SY5Y Neuroblastoma Cells by Augmenting SOD2 Expression and Activity at the Mitochondria, within the Context of a Tumour Stem Cell-like Phenotype
por: Ruggeri, Pierdomenico, et al.
Publicado: (2014)

Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood
por: Sbaffone, Maddalena, et al.
Publicado: (2022)

Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival
por: Guadagni, S., et al.
Publicado: (2019)

Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
por: Farina, Antonietta Rosella, et al.
Publicado: (2020)

NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells
por: Ruggeri, P, et al.
Publicado: (2016)

NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis
por: Ruggeri, P, et al.
Publicado: (2016)

Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting
por: Farina, Antonietta Rosella, et al.
Publicado: (2021)

Familial Melanoma: Diagnostic and Management Implications
por: Rossi, Mariarita, et al.
Publicado: (2019)

Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma
por: Ventura, Alessandra, et al.
Publicado: (2019)

Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases
por: PELLEGRINI, Cristina, et al.
Publicado: (2020)

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study
por: Guadagni, Stefano, et al.
Publicado: (2017)

Intraluminal ileal tumour after right hemicolectomy for cancer: An implantation recurrence or a new cancer? A case report
por: Clementi, Marco, et al.
Publicado: (2017)

The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment
por: Liu, Zhaowen, et al.
Publicado: (2023)

Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
por: Lu, Lu, et al.
Publicado: (2018)

Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study
por: Guadagni, Stefano, et al.
Publicado: (2020)

Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
por: Guadagni, Stefano, et al.
Publicado: (2017)

Advantage of laparoscopic resection for pelvic Schwannoma: Case report and review of the literature
por: Di Furia, Marino, et al.
Publicado: (2018)

MLN51 Stimulates the RNA-Helicase Activity of eIF4AIII
por: Noble, Christian G., et al.
Publicado: (2007)

Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo
por: Zhou, Zhong-yan, et al.
Publicado: (2019)

Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases
por: Guadagni, Stefano, et al.
Publicado: (2022)

Overexpression of patatin-related phospholipase AIIIβ altered the content and composition of sphingolipids in Arabidopsis
por: Li, Maoyin, et al.
Publicado: (2014)

Synergistic anticancer effects of timosaponin AIII and ginsenosides in MG63 human osteosarcoma cells
por: Jung, Okkeun, et al.
Publicado: (2019)

Blockage of Autophagy Increases Timosaponin AIII-Induced Apoptosis of Glioma Cells In Vitro and In Vivo
por: Lee, Chu-Che, et al.
Publicado: (2022)

Star Trk(B): The astrocyte path to neurodegeneration
por: Colombo, Emanuela, et al.
Publicado: (2012)

Timosaponin AIII inhibits melanoma cell migration by suppressing COX‐2 and in vivo tumor metastasis
por: Kim, Ki Mo, et al.
Publicado: (2016)

Successful laparoscopic trans-peritoneal repair of an incisional inguinal hernia, resulting from deep lymph node dissection for melanoma: A case report
por: Clementi, M., et al.
Publicado: (2020)

MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair
por: Pellegrini, Cristina, et al.
Publicado: (2012)

Timosaponin AIII Is Preferentially Cytotoxic to Tumor Cells through Inhibition of mTOR and Induction of ER Stress
por: King, Frank W., et al.
Publicado: (2009)

Rapid and Sensitive Determination of Timosaponin AIII in Rat Plasma by LC-MS/MS and Its Pharmacokinetic Application
por: Liu, Yanping, et al.
Publicado: (2013)

Ginsenoside Rg1 Drives Stimulations of Timosaponin AIII-Induced Anticancer Effects in Human Osteosarcoma Cells
por: Lee, Sang Yeol
Publicado: (2020)

Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
por: Li, Xiaofeng, et al.
Publicado: (2022)

Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor
por: Cong, Yue, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8or81a3ir37ppklqmj8sk046qr